StockData
SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

SkinHealth Systems Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$10.55−0.01 (-0.09%)

Close on Oct 19, 2026

Market cap
$1.37B
P/E (TTM)
–
Dividend yield
–

SkinHealth Systems Inc. revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Consumables$212.71M$208.89M$191.36M$159.64M$120.62M$65.72M$85.16M70.7%+1.8%
Delivery Systems$88.08M$125.40M$206.63M$206.24M$139.46M$53.37M$81.47M29.3%-29.8%

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Americas$203.98M$216.99M$227.71M$243.24M–––67.8%-6.0%
Europe, the Middle East and Africa$68.30M$71.63M$88.09M$68.33M$46.96M$23.18M$28.43M22.7%-4.7%
Asia-Pacific$28.52M$45.67M$82.19M$54.31M$43.70M$14.46M$15.80M9.5%-37.6%
United States––$227.71M$243.24M$169.43M$81.45M$122.40M––

From the segment and revenue-disaggregation notes of SkinHealth Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.